MarketInOut Stock Screener Log In | Sign Up

Bavarian Nordic A/S

VIE • Healthcare • Biotechnology • Quote as of 10/30/2026
Bavarian Nordic A/S stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeVIE
Market Capitalization2,547.22 mln
Float64.56 mln
Earnings Date11/13/2026

EPS

2.61
Solid

P / E

12.56
Fair value

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-1.95
Caution advised

Relative Strength

60 / 100
Outperforming

Debt / Equity

0.01
Debt-free

Business Description

Founded in 1992 and based in Hellerup, Denmark, Bavarian Nordic is a vaccine company with a broad portfolio of approved products protecting against diseases such as smallpox, monkeypox, rabies, cholera, typhoid fever, and tick-borne encephalitis. The company sells its vaccines across more than a dozen countries, including the United States, Germany, Japan, and Australia. Bavarian Nordic is also advancing a new vaccine candidate through clinical trials aimed at preventing certain serious brain infections caused by encephalitis viruses.

Key Fundamentals

EPS2.61
P/E12.56
ROE12.05
ROIC7.29
ROA10.59
Interest Cover66.23
EBITDA, mln365
EV / EBITDA5.27
EV / EBIT7.21
Revenue, mln838
EV / Revenue2.30

Quote Details

Last 32.78
Change -0.12 (-0.36%)
Open 33.38
Volume 0
Turnover 0
Average Volume 16.38

Financial Ratios

Pre-Tax Profit Margin32
Current Ratio6.53
Price / Book1.27
Price / Tangible Book2.26
Price / Free Cash Flow13.98
Debt / Equity0.01
Price / Sales2.73

Financial Strength

Altman Z-Score9.11
Piotroski F-Score 6 / 9
Beneish M-Score-1.95
Price to Intrinsic Value0.85
Price to Graham Number1.07
Shiller PE Ratio47.74

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.31% 45 / 100   
1 Month 10.89% 76 / 100   
2 Months 40.57% 98 / 100   
6 Months 30.6% 88 / 100   
1 Year 2.28% 39 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog